Corporate Officers
Henri A. Termeer
President, Chairman and Chief Executive Officer
Mark R. Bamforth
Senior Vice President, Corporate Operations and Pharmaceuticals
John Butler
President, Genzyme Renal
Earl M. Collier, Jr., Esquire
Executive Vice President
Zoltan Csimma
Senior Vice President, Chief Human Resources Officer
Thomas J. DesRosier, Esquire
Senior Vice President, General Counsel
Richard H. Douglas, Ph.D.
Senior Vice President, Corporate Development
Mark J. Enyedy
President, Genzyme Oncology
David D. Fleming
Group Senior Vice President
Georges Gemayel
Executive Vice President
James A. Geraghty
Senior Vice President
James Kean
Vice President and Corporate Controller
Alison Lawton
Senior Vice President; Regulatory Affairs and Corporate Quality Systems
Roger W. Louis, Esquire
Chief Compliance Officer
Mary McGrane
Senior Vice President, Government Relations
John M. McPherson, Ph.D.
Senior Vice President, Cell and Protein R&D
David Meeker, M.D.
President, Lysosomal Storage Disorder Therapeutics
Ann Merrifield
President, Genzyme Biosurgery
Richard A. Moscicki, M.D.
Senior Vice President, Medical, Clinical and Regulatory Affairs; Chief Medical Officer
Donald E. Pogorzelski
President, Genzyme Diagnostics
Alan E. Smith, Ph.D.
Senior Vice President, Research; Chief Scientific Officer
Sandford D. Smith
President, International Group
Gail F. Sullivan
Vice President and Treasurer
Peter Wirth, Esquire
Executive Vice President, Legal, and Corporate Development; Chief Legal Officer; Secretary
Michael S. Wyzga
Executive Vice President, Finance; Chief Financial and Accounting Officer
|
Home
